EGFR and cancer: The autophagy response provides the allosteric degradation of the EGFR, leading to a decrease in the activity of the downstream signaling pathways, followed by disabling the phosphorylation of the Bim sensor protein and the destruction of the cellular cytoskeleton, which, ultimately, leads to the death of cancer cells (Figure 6B).